Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review

Combination Olanzapine and Samidorphan for the Management of Schizophrenia and Bipolar 1 Disorder in Adults: A Narrative Review

Schizophrenia is a debilitating psychotic disorder characterized by positive symptoms such as delusions, hallucinations, and disorganized thoughts, and negative symptoms like lack of effect or motivation. Bipolar 1 disorder (B1D) is a psychiatric illness characterized by recurrent manic episodes in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hannah W. Haddad, Elena Boardman, Brooke Williams, Rama Mouhaffel, Adam M. Kaye, Alan D. Kaye
Format:	Article
Language:	English
Published:	Open Medical Publishing 2022-04-01
Series:	Health Psychology Research
Online Access:	https://doi.org/10.52965/001c.34224
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Insights into audio-visual temporal perception in bipolar disorder and schizophrenia
by: Monica Gori, et al.
Published: (2025-01-01)

Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms
by: Xiangning Chen, et al.
Published: (2025-02-01)

Living with bipolar disorder: A study of the lived experience of Saudi employees diagnosed with bipolar disorder in the workplace
by: Hessah Alzahrani
Published: (2024-12-01)

Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-10-01)

Delusions of Glass Under Skin: An Unusual Case of Somatic-Type Delusional Disorder Treated with Olanzapine
by: Nicholas Comardelle, et al.
Published: (2022-05-01)

Insight in patients with bipolar disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study)
by: Sandeep Grover, et al.
Published: (2023-07-01)

Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update
by: Hannah W Haddad, et al.
Published: (2022-07-01)

Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
by: Kunal Maini, et al.
Published: (2021-06-01)

Disability and its correlates among persons with bipolar disorder: Exploratory findings from the bipolar disorder course and outcome study from India (BiD-CoIN study)
by: Sandeep Grover, et al.
Published: (2023-07-01)

Clinical practice guidelines on cognitive impairment in bipolar disorders – Assessment and management
by: Muralidharan Kesavan, et al.
Published: (2025-01-01)

The Role of Vitamin D in the Management of Chronic Pain in Fibromyalgia: A Narrative Review
by: Hannah W. Haddad, et al.
Published: (2021-06-01)

Heterogeneity analysis provides evidence for a genetically homogeneous subtype of bipolar-disorder.
by: Caroline C McGrouther, et al.
Published: (2025-01-01)

Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01)

Biological rhythm, sleep quality and functionality in the euthymic period in patients diagnosed with bipolar disorder
by: Mehmet Baltaci̇oglu, et al.
Published: (2024-04-01)

Reduction Behavior of Olanzapine and Its Differential Pulse Voltammetric Determination in Human Urine and Pharmaceuticals
by: Sultan Yağmur
Published: (2020-12-01)

Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
by: Amber N. Edinoff, et al.
Published: (2022-09-01)

Differentiation value of miR-26b for major depressive disorder, schizophrenia, generalized anxiety disorder
by: Lingming Kong, et al.
Published: (2023-07-01)

RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study
by: Andrea Miranda-Mendizabal, et al.
Published: (2025-02-01)

Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review
by: Hannah W Haddad, et al.
Published: (2022-01-01)

Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01)

Individualized prediction of multi-domain intelligence quotient in bipolar disorder patients using resting-state functional connectivity
by: Xiaoyu Li, et al.
Published: (2025-03-01)

Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer’s Disease: A comprehensive review
by: Hannah W. Haddad, et al.
Published: (2022-07-01)

The use of a smartphone app for self-monitoring by patients with bipolar disorder being treated in a primary care setting
by: Omar H. Elsayed, et al.
Published: (2025-01-01)

Personalised transcranial magnetic stimulation for treatment-resistant depression, depression with comorbid anxiety and negative symptoms of schizophrenia: a narrative review
by: Xiao Wei Tan, et al.
Published: (2024-10-01)

Psychiatric disorders in children and adolescents with temporal lobe epilepsy: A narrative review
by: Pietro Cappelletto, et al.
Published: (2025-02-01)

Improving the Utility, Safety, and Ethical Use of a Passive Mood-Tracking App for People With Bipolar Disorder Using Coproduction: Qualitative Focus Group Study
by: Laurence Astill Wright, et al.
Published: (2025-02-01)

Efficacy of identifying Treatment-Resistant and non-Treatment-Resistant Schizophrenia using niacin skin flushing response combined with clinical feature
by: Jizhi Wang, et al.
Published: (2025-02-01)

Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
by: Yethindra Vityala, et al.
Published: (2024-09-01)

Validation of the shortest version of the eating attitude test (EAT-7) as a screening tool for disordered eating in patients with first-episode schizophrenia
by: Feten Fekih-Romdhane, et al.
Published: (2025-02-01)

Development and Validation of Patient Information Leaflet for Schizophrenia
by: C. G. Deepak, et al.
Published: (2025-01-01)

Schizophrenia and Nicotine - A Bittersweet Psychiatric Story
by: Satrajit Ghosal, et al.
Published: (2025-01-01)

Reducing the Accumulative Charge on Fabric Filter Surfaces by Using a Bipolar Precharger
by: Pei Jia, et al.
Published: (2022-04-01)

The Role of Dopamine in Impulsivity and Substance Abuse: A Narrative Review
by: Connor J Plaisance, et al.
Published: (2024-11-01)

Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder
by: Christopher L Robinson, et al.
Published: (2022-09-01)

Role of Ketamine in the Treatment of Psychiatric Disorders
by: Sahar Derakhshanian, et al.
Published: (2021-06-01)

pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
by: Noeen Sarfraz, et al.
Published: (2022-05-01)

Association between treatment resistance and cognitive function in schizophrenia
by: Jiaqian Sun, et al.
Published: (2024-10-01)

The negative off-response driven by M-cone and depolarizing bipolar cell in the rat electroretinogram
by: Tao Chen, et al.
Published: (2025-02-01)

Surgical techniques in tonsillectomy: A comparative analysis of cold steel dissection and bipolar diathermy.
by: Nisar Akber Khan, et al.
Published: (2024-09-01)

Estimating the Prevalence of Schizophrenia in the General Population of Japan Using an Artificial Neural Network–Based Schizophrenia Classifier: Web-Based Cross-Sectional Survey
by: Pichsinee Choomung, et al.
Published: (2025-01-01)